Africa bears over 20% of the global disease burden but contributes to less than 1% of global health research and development. This gap is our mandate. At Immunite Ltd., we are closing this disparity by building a world-class research hub on African soil, for African people.
Vaccine Research
Focus on malaria, viral, and emerging infectious diseases.
Preclinical studies and immunogenicity testing.
Partnerships with universities and research consortia.